Notice of conference call and webcast
15 Juli 2008 - 11:00PM
PR Newswire (US)
Second quarter 2008 financial results VANCOUVER, July 15
/PRNewswire-FirstCall/ -- Angiotech Pharmaceuticals, Inc.
(NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP), a global specialty
pharmaceutical and medical device company, will host a conference
call discussing its financial results for the second quarter ended
June 30, 2008. Monday, July 28, 2008 at 11:00 AM ET (8:00 AM
Pacific, 9:00 AM Mountain, 10:00 AM Central) Dial information is as
follows: North America (toll-free): (800) 706-7745 International:
(617) 614-3472 Enter passcode: 52264044 A live webcast will be
available to all interested parties through Angiotech's website at
http://www.angiotech.com/ in the Investor Relations section. A
press release announcing Angiotech's financial results will be
issued prior to the conference call at approximately 8:00 AM ET
(5:00 AM Pacific, 6:00 AM Mountain, 7:00 AM Central). A replay
archive of the conference call will be available until August 4,
2008. Replay information is as follows: North America: (888)
286-8010 International: (617) 801-6888 Enter passcode: 85663575
About Angiotech Pharmaceuticals Angiotech Pharmaceuticals, Inc. is
a global specialty pharmaceutical and medical device company with
over 1,500 dedicated employees. Angiotech discovers, develops and
markets innovative treatment solutions for diseases or
complications associated with medical device implants, surgical
interventions and acute injury. To find out more about Angiotech
(NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP) please visit our website at
http://www.angiotech.com/. DATASOURCE: Angiotech Pharmaceuticals,
Inc. CONTACT: Sage Baker, Angiotech Pharmaceuticals, Inc., (604)
221-6933, ; Elizabeth Sol, Angiotech Pharmaceuticals, Inc., (604)
221-6920,
Copyright
Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ:ANPI)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ:ANPI)
Historical Stock Chart
Von Jul 2023 bis Jul 2024
Echtzeit-Nachrichten über Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ): 0 Nachrichtenartikel
Weitere Angiotech Pharmaceuticals - Common Shares (MM) News-Artikel